Non-nutritional effects of food: An underutilized and understudied therapeutic tool in chronic gastrointestinal diseases

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue S4, 2013, Pages 37-40

  Gibson, Peter R ^a   Muir, Jane G ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adverse effects; Carbohydrates; Chronic gastrointestinal disease; Clinical trial; Dietary therapy; Gluten; Gut microbiota; Nutrition

Indexed keywords

CARBOHYDRATE;

ARTICLE; CHRONIC DISEASE; DIET; DIET THERAPY; DIETARY INTAKE; EVIDENCE BASED PRACTICE; FOOD; FOOD COMPOSITION; GASTROINTESTINAL DISEASE; HUMAN; NUTRITION; NUTRITIONAL ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL;

ADVERSE EFFECTS; CARBOHYDRATES; CHRONIC GASTROINTESTINAL DISEASE; CLINICAL TRIAL; DIETARY THERAPY; GLUTEN; GUT MICROBIOTA; NUTRITION;

CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; DIET THERAPY; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL DISEASES; GLUTENS; HUMANS; INTESTINES; MONOSACCHARIDES; NUTRITIVE VALUE; OLIGOSACCHARIDES; PATIENT COMPLIANCE; POLYMERS;

EID: 84897632379     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12253     Document Type: Article

References (33)

1. Wikipedia contributors. Nutrition. 2013. Cited 1 July 2013. Available from URL: http://en.wikipedia.org/wiki/Nutrition
2. Hugot JP, Alberti C, Berrebi D, Bingen E, Cézard JP. Crohn's disease: the cold chain hypothesis. Lancet 2003; 362: 2012-2015.
3. Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 2002; 61: 123-130.
4. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 2011; 106: 563-573.
5. Bartel G, Weiss I, Turetschek K etal. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm. Bowel Dis. 2008; 14: 374-382.
6. Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment. Pharmacol. Ther. 2005; 21: 1399-1409.
7. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J. Crohns Colitis 2009; 3: 8-14.
8. Lopez-Ceron M, Pellise M. Biology and diagnosis of aberrant crypt foci. Colorectal Dis. 2012; 14: e157-164.
9. Marshall JR. Nutrition and colon cancer prevention. Curr. Opin. Clin. Nutr. Metab. Care 2009; 12: 539-543.
10. Yao CK, Gibson PR, Shepherd SJ. Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am. J. Gastroenterol. 2013; 108: 748-758.
11. Makris A, Foster GD. Dietary approaches to the treatment of obesity. Psychiatr. Clin. North Am. 2011; 34: 813-827.
12. Kurppa K, Lauronen O, Collin P etal. Factors associated with dietary adherence in celiac disease: a nationwide study. Digestion 2012; 86: 309-314.
13. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J. Am. Diet. Assoc. 2006; 106: 1631-1639.
14. Anonymous. (n.d.). Cited May 2013. Available from URL: http://med.monash.edu.au/cecs/gastro/fodmap/iphone-app.html
15. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin. Gastroenterol. Hepatol. 2008; 6: 765-771.
16. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2011; 24: 487-495.
17. Staudacher HM, Lomer MC, Anderson JL etal. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr. 2012; 142: 1510-1518.
18. Ong DK, Mitchell SB, Barrett JS etal. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J. Gastroenterol. Hepatol. 2010; 25: 1366-1373.
19. Halmos E, Shepherd S, Power V, Gibson P, Muir J. Restriction of dietary FODMAPs reduces gastrointestinal symptoms compared with a typical Australian intake in patients with irritable bowel syndrome: a randomised controlled cross-over trial. J. Gastroenterol. Hepatol. 2012; 27 (Suppl. 4): 141-142.
20. Ludvigsson JF, Leffler DA, Bai JC etal. The Oslo definitions for coeliac disease and related terms. Gut 2012; 62: 43-52.
21. Biesiekierski JR, Rosella O, Rose R etal. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J. Hum. Nutr. Diet. 2011; 24: 154-176.
22. Carroccio A, Mansueto P, Iacono G etal. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am. J. Gastroenterol. 2012; 107: 1898-1906.
23. Biesiekierski JR, Newnham ED, Irving PM etal. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am. J. Gastroenterol. 2011; 106: 508-514.
24. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates. Gastroenterology. 2013 May 4. doi:pii: S0016-5085(13)00702-6.
25. de Souza RJ, Swain JF, Appel LJ, Sacks FM. Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. Am. J. Clin. Nutr. 2008; 88: 1-11.
26. Shepherd SJ, Gibson PR. Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease. J. Hum. Nutr. Diet. 2012 Nov 30. doi: 10.1111/jhn.12018
27. Gray P, Mehr S, Katelaris C. Adverse events in children prescribed natural salicylate elimination diets: a Sydney-based multicentre case series. Intern. Med. J. 2012; 42 (Suppl. 4): 9.
28. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J. Gastroenterol. Hepatol. 2010; 25: 252-258.
29. Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol. Med. Microbiol. 2007; 51: 562-568.
30. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 2008; 8: 232.
31. Nistal E, Caminero A, Vivas S etal. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 2012; 94: 1724-1729.
32. Benjamin JL, Hedin CR, Koutsoumpas A etal. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011; 60: 923-929.
33. James SL, Muir JG, Gibson PR. Abnormal distal colonic environment is not influenced by dietary supplementation with fiber in ulcerative colitis in remission. J. Gastroenterol. Hepatol. 2008; 23 (Suppl. 4): A208.